Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 3
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2447CITRNAsHumanUpregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.26 ) Prognosticless (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients p < 0.01Tissue19945130
2551Isocitrate dehydrogenase [NADP] (cytoplasmic), Fumarate hydratase (mitochondrial), Enoyl-CoA hydratase (mitochondrial), Betaine-homocysteine S-methyltransferase, Serotransferrin precursorProteinHumanDownregulated in well-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300
2553Keratin type I cytoskeletal 10, Catalase, Aldehyde dehydrogenase (mitochondrial), GlutathioneS-transferase A1, Antioxidant protein 2, Isocitrate dehydrogenase [NADP] (cytoplasmic), Formiminotransferase-cyclodeaminase, Carbonic anhydrase I, Fructose bisphosphate aldolase B, Arginase 1, Fructose-1, 6-ProteinHumanDownregulated in poorly-differentiated HCC (with 2 fold change) DiagnosticHCC v/s non-tumor p < 0.05Tissue15852300

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top